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Heart Failure
Low CoQ10 Levels Associated With Worse Survival in CHF Patients
CoenzymeQ10 (CoQ10) is an essential cofactor for myocardial adenosine triphos-phate generation; low levels may impair cardiac energy reserves. Molyneux and
colleagues measured CoQ10 levels in over 200 patients hospitalized with chronic heart
failure (CHF) who were then followed for total mortality. There was a significant
correlation between CoQ10 and total cholesterol, and an inverse correlation between
CoQ10 and N-terminal peptide of B-type natriuretic peptide (NT-proBNP). CoQ10
was an independent predictor of survival with a higher strength of association than
NT-proBNP. CoQ10 deficiency may be detrimental to the long-term prognosis of
patients with CHF. See page 1435. See figure.
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Heart Rhythm Disorders
CRT Responders Show a Decrease in VAs
Cardiac resynchronization therapy (CRT) can result in significant reverse remod-eling of the enlarged left ventricle. Di Biase and colleagues studied the relation-
ship between reverse remodeling and ventricular arrhythmias (VAs) in nearly 400
patients. Spontaneous VAs detected by the device were reviewed and validated. Those
patients who had a10% reduction in left ventricular end-systolic volume, classified
as responders to CRT, had significantly fewer VAs than nonresponders. In patients
who respond favorably to CRT, a reduction in VAs occurs during the first fewmonths
of therapy. See page 1442. See figure.
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Cardiac Imaging
“Step-and-Shoot” CT Angiography Significantly Reduces Radiation Exposure
Maruyama and colleagues compared the radiation dose received and the imagequality of prospectively electrocardiogram (ECG)-gated multidetector-row
computed tomography coronary angiography (MDCT-CA) and retrospectivelyECG-
gated helical scanning with dose modulation. In this select population,95% of the
coronary segments were considered assessable for both techniques, and there was
similar sensitivity and specificity for both techniques compared with findings at
traditional coronary angiography. The effective radiation dose with prospective gating
was 79% lower thanwith retrospective gating. This study shows thatMDCT-CAwith
prospective gating can significantly reduce radiation exposure without compromising
image quality. See pages 1450 and 1456. See figure.
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Biomarkers
ST2 Correlates With HF Severity and Risk of Death in CHF Patients
TheST2 gene is amember of the interleukin-1 receptor family whose transcription incardiac myocytes and fibroblasts is markedly up-regulated by mechanical strain.
Rehman and colleagues assayed a soluble fragment of this gene that circulates in the plasma
in over 300 subjects with acute heart failure (HF). ST2 values positively correlated with
markers of poor prognosis, including B-type natriuretic peptide, amino terminal B-type
natriureticpeptide,NewYorkHeartAssociationfunctionalclass, and1-yearmortality.ST2
appears tobeausefulbiomarker thatmayhelptoelucidate therelationshipbetweenHFand
inflammation. See pages 1458 and 1466. See figure.
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Hypertension
Polymorphism in CHGA Gene Associated With Hypertension
Chromogranin A (CHGA) is a protein that is stored with catecholamines insecretory vesicles in the adrenal medulla and post-ganglionic sympathetic axons.
Chen and colleagues performed a series of studies assessing the impact of polymor-
phisms in this gene on resting blood pressure (BP), BP response to cold pressor
challenge, and circulating levels of norepinephrine. The results suggest that a common
polymorphism in the 3=-untranslated region (C87T) can significantly affect BP by
modulating the release of catecholamines from these secretory vesicles, otherwise
known as chromaffin granules. See page 1468. See figure.(continued on page A-31)
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Hypertension
Reduction in Heart Rate With Beta-Blockers Linked to Increased Mortality
Previous studies in patients with acute myocardial infarction (MI), stable angina,and heart failure have shown that the reduction in heart rate by beta-blockers is
closely linked to the beneficial effects. Bangalore and colleagues performed a meta-
analysis to determine if the relationship holds true for patients with hypertension. In 9
trials, a lower heart rate was associated with an increased risk of all-cause mortality,
cardiovascularmortality,MI, stroke, and heart failure. In patients with hypertension, a
beta-blocker–induced reduction in heart rate appears to increase the risk of cardiovas-
cular events, possibly by increasing central aortic pressure compared with other medi-
cations with similar reductions in peripheral blood pressure. See pages 1482 and
1490. See figure.
Year in Cardiology Series
2008 Research Highlights for Congenital Heart Disease
Graham reviews and summarizes several articles published in 2008with a focus onpatients with congenital heart disease. This paper includes summaries of several
articles that range from the morbidity of surgery in infants to long-term follow-up of
post-Fontan patients to the efficacy of clopidogrel in children. See page 1492.
